Metropolitan Life Insurance Company (MetLife)’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,284
Closed -$48.1K 1669
2024
Q1
$48.1K Hold
2,284
﹤0.01% 1423
2023
Q4
$41K Hold
2,284
﹤0.01% 1550
2023
Q3
$37.6K Hold
2,284
﹤0.01% 1565
2023
Q2
$45.7K Hold
2,284
﹤0.01% 1472
2023
Q1
$43.2K Sell
2,284
-414
-15% -$7.83K ﹤0.01% 1473
2022
Q4
$61.2K Hold
2,698
﹤0.01% 1345
2022
Q3
$71.3K Hold
2,698
﹤0.01% 1225
2022
Q2
$66.6K Hold
2,698
﹤0.01% 1318
2022
Q1
$89.5K Sell
2,698
-8,295
-75% -$275K ﹤0.01% 1265
2021
Q4
$359K Hold
10,993
﹤0.01% 1632
2021
Q3
$461K Hold
10,993
0.01% 1518
2021
Q2
$427K Buy
10,993
+525
+5% +$20.4K 0.01% 1617
2021
Q1
$357K Sell
10,468
-72
-0.7% -$2.46K 0.01% 1627
2020
Q4
$478K Hold
10,540
0.01% 1378
2020
Q3
$290K Hold
10,540
﹤0.01% 1560
2020
Q2
$388K Sell
10,540
-302
-3% -$11.1K 0.01% 1388
2020
Q1
$351K Hold
10,842
0.01% 1260
2019
Q4
$444K Sell
10,842
-457
-4% -$18.7K 0.01% 1403
2019
Q3
$402K Buy
11,299
+1,040
+10% +$37K 0.01% 1428
2019
Q2
$527K Hold
10,259
0.01% 1269
2019
Q1
$588K Hold
10,259
0.01% 1190
2018
Q4
$430K Hold
10,259
0.01% 1288
2018
Q3
$775K Buy
10,259
+985
+11% +$74.4K 0.01% 1072
2018
Q2
$665K Hold
9,274
0.01% 1128
2018
Q1
$277K Buy
9,274
+541
+6% +$16.1K ﹤0.01% 1674
2017
Q4
$290K Sell
8,733
-9,767
-53% -$324K ﹤0.01% 1643
2017
Q3
$610K Buy
18,500
+1,905
+11% +$62.8K ﹤0.01% 1553
2017
Q2
$328K Hold
16,595
﹤0.01% 1999
2017
Q1
$320K Hold
16,595
﹤0.01% 1958
2016
Q4
$308K Hold
16,595
﹤0.01% 2076
2016
Q3
$232K Sell
16,595
-387
-2% -$5.41K ﹤0.01% 2245
2016
Q2
$136K Buy
+16,982
New +$136K ﹤0.01% 2559